FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4255721613> ?p ?o ?g. }

• W4255721613 endingPage "603" @default.
• W4255721613 startingPage "593" @default.
• W4255721613 abstract "The world’s population is growing at a tremendous rate, affecting growth and development. Apart from this population growth, unintended pregnancies resulting in elective abortions continue to be a major public health issue. In over half of these unintended pregnancies, the women have used some type of contraception. Thus, there is an urgent need for a better method of contraception that is acceptable, effective and available. The contraceptive choices available to women at this time include steroid contraceptives, intrauterine devices, barrier methods, spermicides, natural family planning, male and female sterilisation, and recently available emergency contraceptives. Contraceptive vaccines (CVs) may provide viable and valuable alternatives that can fulfill most, if not all, properties of an ideal contraceptive. Since both the developed and most of the developing nations have an infrastructure for mass immunisation, the development of vaccines for contraception is an exciting proposition. The molecules that are being explored for CV development either target gamete production (gonadotropin releasing hormone, follicle-stimulating hormone and luteinising hormone), gamete function (zona pellucida [ZP] proteins and sperm antigens) or gamete outcome (human chorionic gonadotropin [hCG]). Disadvantages of CVs targeting gamete production are that they affect sex steroids and/or show only a partial effect in reducing fertility. CVs targeting gamete function are better choices. Vaccines based on ZP proteins are quite efficacious in producing contraceptive effects. However, they invariably induce oophoritis affecting sex steroids. Sperm antigens constitute the most promising and exciting targets for CVs. Several sperm-specific antigens have been delineated in several laboratories and are being actively explored for CV development. Antisperm antibody-mediated immunoinfertility provides a naturally occurring model to indicate how an antisperm vaccine will work in humans. Vaccines targeting gamete outcome primarily focus on the hCG molecule. The hCG vaccine is the first vaccine to undergo phase I and II clinical trials in humans. Both the efficacy and the lack of immunotoxicity have been reasonably well demonstrated for this vaccine. The present studies focus on increasing the immunogenicity and efficacy of this birth control vaccine." @default.
• W4255721613 created "2022-05-12" @default.
• W4255721613 creator A5032262345 @default.
• W4255721613 date "2005-01-01" @default.
• W4255721613 modified "2023-10-11" @default.
• W4255721613 title "Contraceptive Vaccines" @default.
• W4255721613 cites W127566521 @default.
• W4255721613 cites W1481794779 @default.
• W4255721613 cites W1573027078 @default.
• W4255721613 cites W1579470329 @default.
• W4255721613 cites W1623183308 @default.
• W4255721613 cites W1777004889 @default.
• W4255721613 cites W1972119304 @default.
• W4255721613 cites W1975821522 @default.
• W4255721613 cites W1980208663 @default.
• W4255721613 cites W1987573862 @default.
• W4255721613 cites W1991013766 @default.
• W4255721613 cites W1992025321 @default.
• W4255721613 cites W1995277973 @default.
• W4255721613 cites W1997055092 @default.
• W4255721613 cites W1998683445 @default.
• W4255721613 cites W2000064765 @default.
• W4255721613 cites W2001706663 @default.
• W4255721613 cites W2003116956 @default.
• W4255721613 cites W2007626679 @default.
• W4255721613 cites W2010217031 @default.
• W4255721613 cites W2023594183 @default.
• W4255721613 cites W2032162664 @default.
• W4255721613 cites W2033463516 @default.
• W4255721613 cites W2038143969 @default.
• W4255721613 cites W2045630933 @default.
• W4255721613 cites W2047394600 @default.
• W4255721613 cites W2048214054 @default.
• W4255721613 cites W2052982018 @default.
• W4255721613 cites W2057142441 @default.
• W4255721613 cites W2058541879 @default.
• W4255721613 cites W2062127675 @default.
• W4255721613 cites W2069107664 @default.
• W4255721613 cites W2071985058 @default.
• W4255721613 cites W2076536630 @default.
• W4255721613 cites W2077700036 @default.
• W4255721613 cites W2078976297 @default.
• W4255721613 cites W2086703698 @default.
• W4255721613 cites W2102966272 @default.
• W4255721613 cites W2104796838 @default.
• W4255721613 cites W2116682384 @default.
• W4255721613 cites W2121853791 @default.
• W4255721613 cites W2121943710 @default.
• W4255721613 cites W2124072977 @default.
• W4255721613 cites W2124477598 @default.
• W4255721613 cites W2125785701 @default.
• W4255721613 cites W2131518253 @default.
• W4255721613 cites W2138080570 @default.
• W4255721613 cites W2138368013 @default.
• W4255721613 cites W2143308988 @default.
• W4255721613 cites W2151772071 @default.
• W4255721613 cites W2154171512 @default.
• W4255721613 cites W2169602923 @default.
• W4255721613 cites W2169981277 @default.
• W4255721613 cites W2203043450 @default.
• W4255721613 cites W2410589319 @default.
• W4255721613 cites W2414001849 @default.
• W4255721613 cites W2461102852 @default.
• W4255721613 cites W36034434 @default.
• W4255721613 cites W84031401 @default.
• W4255721613 doi "https://doi.org/10.2165/00003495-200565050-00002" @default.
• W4255721613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15748095" @default.
• W4255721613 hasPublicationYear "2005" @default.
• W4255721613 type Work @default.
• W4255721613 citedByCount "21" @default.
• W4255721613 countsByYear W42557216132014 @default.
• W4255721613 countsByYear W42557216132015 @default.
• W4255721613 countsByYear W42557216132016 @default.
• W4255721613 countsByYear W42557216132018 @default.
• W4255721613 countsByYear W42557216132021 @default.
• W4255721613 countsByYear W42557216132022 @default.
• W4255721613 crossrefType "journal-article" @default.
• W4255721613 hasAuthorship W4255721613A5032262345 @default.
• W4255721613 hasBestOaLocation W42557216131 @default.
• W4255721613 hasConcept C16685009 @default.
• W4255721613 hasConcept C2776803348 @default.
• W4255721613 hasConcept C2779076696 @default.
• W4255721613 hasConcept C2780099242 @default.
• W4255721613 hasConcept C2781087480 @default.
• W4255721613 hasConcept C2908647359 @default.
• W4255721613 hasConcept C29456083 @default.
• W4255721613 hasConcept C2986817661 @default.
• W4255721613 hasConcept C518429986 @default.
• W4255721613 hasConcept C71924100 @default.
• W4255721613 hasConcept C99454951 @default.
• W4255721613 hasConceptScore W4255721613C16685009 @default.
• W4255721613 hasConceptScore W4255721613C2776803348 @default.
• W4255721613 hasConceptScore W4255721613C2779076696 @default.
• W4255721613 hasConceptScore W4255721613C2780099242 @default.
• W4255721613 hasConceptScore W4255721613C2781087480 @default.
• W4255721613 hasConceptScore W4255721613C2908647359 @default.
• W4255721613 hasConceptScore W4255721613C29456083 @default.
• W4255721613 hasConceptScore W4255721613C2986817661 @default.

• next